West Pharmaceutical Services, Inc.
WST
$251.38
$0.130.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.64% | 6.22% | 46.77% | -30.98% | -4.34% |
| Total Depreciation and Amortization | 9.30% | 3.86% | 3.50% | -1.72% | 1.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -180.17% | 51.25% | 1,700.00% | 88.10% | -205.00% |
| Change in Net Operating Assets | 3,790.48% | 151.22% | -4,200.00% | -99.57% | 23,600.00% |
| Cash from Operations | 27.33% | 11.35% | 36.86% | -31.93% | 5.55% |
| Capital Expenditure | -20.22% | 15.82% | -5.47% | 32.03% | -29.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 112.50% |
| Cash from Investing | -20.22% | 15.82% | -5.47% | 31.97% | -27.65% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 0.00% | 0.00% | -50.00% | -100.00% | 99.92% |
| Issuance of Common Stock | 15.00% | -23.08% | 18.18% | 41.94% | -48.33% |
| Repurchase of Common Stock | -100.00% | 80.00% | 99.63% | -149.08% | -4.20% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.64% | 0.00% | 0.66% | 0.65% | -5.52% |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -1.74% | 22.82% | 89.86% | -113.35% | -6.99% |
| Foreign Exchange rate Adjustments | 86.11% | -119.46% | 117.65% | 137.44% | -304.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.04% | 12.61% | 231.22% | -1,176.19% | -114.09% |